|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
Crystal structure of epstein-barr virus il-10 complexed with the soluble il-10r1 chain
|
|
Structure:
|
 |
Viral interleukin-10 homolog. Chain: l. Fragment: residues 26-170. Synonym: vil-10, bcrf1 protein, 20 kda protein. Engineered: yes. Interleukin-10 receptor alpha chain. Chain: r. Fragment: extracellular domain, residues 22-235. Synonym: il-10r-a, il-10r1.
|
|
Source:
|
 |
Human herpesvirus 4. Epstein-barr virus. Organism_taxid: 10376. Strain: gd1. Gene: bcrf1. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008. Homo sapiens. Human.
|
|
Biol. unit:
|
 |
Tetramer (from PDB file)
|
|
Resolution:
|
 |
|
2.80Å
|
R-factor:
|
0.261
|
R-free:
|
0.315
|
|
|
Authors:
|
 |
S.I.Yoon,B.C.Jones,N.J.Logsdon,M.R.Walter
|
Key ref:
|
 |
S.I.Yoon
et al.
(2005).
Same structure, different function crystal structure of the Epstein-Barr virus IL-10 bound to the soluble IL-10R1 chain.
Structure,
13,
551-564.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
06-Dec-04
|
Release date:
|
03-May-05
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure
13:551-564
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Same structure, different function crystal structure of the Epstein-Barr virus IL-10 bound to the soluble IL-10R1 chain.
|
|
S.I.Yoon,
B.C.Jones,
N.J.Logsdon,
M.R.Walter.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Human IL-10 (hIL-10) is a cytokine that modulates diverse immune responses. The
Epstein-Barr virus (EBV) genome contains an IL-10 homolog (vIL-10) that shares
high sequence and structural similarity with hIL-10. Although vIL-10 suppresses
inflammatory responses like hIL-10, it cannot activate many other
immunostimulatory functions performed by the cellular cytokine. These functional
differences have been correlated with the approximately 1000-fold lower affinity
of vIL-10, compared to hIL-10, for the IL-10R1 receptor chain. To define the
structural basis for these observations, crystal structures of vIL-10 and a
vIL-10 point mutant were determined bound to the soluble IL-10R1 receptor
fragment (sIL-10R1) at 2.8 and 2.7 A resolution, respectively. The structures
reveal that subtle changes in the conformation and dynamics of the vIL-10 AB and
CD loops and an orientation change of vIL-10 on sIL-10R1 are the main factors
responsible for vIL-10's reduced affinity for sIL-10R1 and its distinct
biological profile.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 2.
Figure 2. Viral and Human IL-10 Orientations and
Interdomain Angles (A) hIL-10, (B) vIL-10, and (C) cmvIL-10
dimers bound to sIL-10R1 are shown. The interdomain angles of
each IL-10 are shown at the top of each complex. The rotations
(in degrees) of each IL-10 domain on the surface of sIL-10R1 are
denoted by arrows where the movement is from the circle to the
arrowhead. For cmvIL-10/sIL-10R1 complex, the rotation of each
sIL-10R1 relative to the hIL-10/sIL-10R1 complex is also shown.
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from Cell Press:
Structure
(2005,
13,
551-564)
copyright 2005.
|
|
| |
Figure was
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.Elegheert,
N.Bracke,
P.Pouliot,
I.Gutsche,
A.V.Shkumatov,
N.Tarbouriech,
K.Verstraete,
A.Bekaert,
W.P.Burmeister,
D.I.Svergun,
B.N.Lambrecht,
B.Vergauwen,
and
S.N.Savvides
(2012).
Allosteric competitive inactivation of hematopoietic CSF-1 signaling by the viral decoy receptor BARF1.
|
| |
Nat Struct Mol Biol,
19,
938-947.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.T.Doncheva,
K.Klein,
F.S.Domingues,
and
M.Albrecht
(2011).
Analyzing and visualizing residue networks of protein structures.
|
| |
Trends Biochem Sci,
36,
179-182.
|
 |
|
|
|
|
 |
Y.Chao,
Y.Jing,
Y.Jia,
Y.Wang,
C.Zhao,
and
B.Luo
(2011).
Conservation and mutation of viral interleukin-10 gene in gastric carcinomas and nasopharyngeal carcinomas.
|
| |
J Med Virol,
83,
644-650.
|
 |
|
|
|
|
 |
A.P.Hinck
(2010).
Class II cytokine common receptors: something old, something new.
|
| |
Structure,
18,
551-552.
|
 |
|
|
|
|
 |
A.Zdanov
(2010).
Structural analysis of cytokines comprising the IL-10 family.
|
| |
Cytokine Growth Factor Rev,
21,
325-330.
|
 |
|
|
|
|
 |
S.I.Yoon,
B.C.Jones,
N.J.Logsdon,
B.D.Harris,
A.Deshpande,
S.Radaeva,
B.A.Halloran,
B.Gao,
and
M.R.Walter
(2010).
Structure and mechanism of receptor sharing by the IL-10R2 common chain.
|
| |
Structure,
18,
638-648.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.Slobedman,
P.A.Barry,
J.V.Spencer,
S.Avdic,
and
A.Abendroth
(2009).
Virus-encoded homologs of cellular interleukin-10 and their control of host immune function.
|
| |
J Virol,
83,
9618-9629.
|
 |
|
|
|
|
 |
E.O.Glocker,
D.Kotlarz,
K.Boztug,
E.M.Gertz,
A.A.Schäffer,
F.Noyan,
M.Perro,
J.Diestelhorst,
A.Allroth,
D.Murugan,
N.Hätscher,
D.Pfeifer,
K.W.Sykora,
M.Sauer,
H.Kreipe,
M.Lacher,
R.Nustede,
C.Woellner,
U.Baumann,
U.Salzer,
S.Koletzko,
N.Shah,
A.W.Segal,
A.Sauerbrey,
S.Buderus,
S.B.Snapper,
B.Grimbacher,
and
C.Klein
(2009).
Inflammatory bowel disease and mutations affecting the interleukin-10 receptor.
|
| |
N Engl J Med,
361,
2033-2045.
|
 |
|
|
|
|
 |
L.Bortesi,
M.Rossato,
F.Schuster,
N.Raven,
J.Stadlmann,
L.Avesani,
A.Falorni,
F.Bazzoni,
R.Bock,
S.Schillberg,
and
M.Pezzotti
(2009).
Viral and murine interleukin-10 are correctly processed and retain their biological activity when produced in tobacco.
|
| |
BMC Biotechnol,
9,
22.
|
 |
|
|
|
|
 |
B.C.Jones,
N.J.Logsdon,
and
M.R.Walter
(2008).
Structure of IL-22 bound to its high-affinity IL-22R1 chain.
|
| |
Structure,
16,
1333-1344.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.J.Lazarus,
M.A.Kay,
A.L.McCarter,
and
R.M.Wooten
(2008).
Viable Borrelia burgdorferi enhances interleukin-10 production and suppresses activation of murine macrophages.
|
| |
Infect Immun,
76,
1153-1162.
|
 |
|
|
|
|
 |
R.D.Irons,
and
A.T.Le
(2008).
Dithiocarbamates and viral IL-10 collaborate in the immortalization and evasion of immune response in EBV-infected human B lymphocytes.
|
| |
Chem Biol Interact,
172,
81-92.
|
 |
|
|
|
|
 |
S.G.Gruber,
M.Gloria Luciani,
P.Grundtner,
A.Zdanov,
and
C.Gasche
(2008).
Differential signaling of cmvIL-10 through common variants of the IL-10 receptor 1.
|
| |
Eur J Immunol,
38,
3365-3375.
|
 |
|
|
|
|
 |
K.Kanai,
Y.Satoh,
H.Yamanaka,
A.Kawaguchi,
K.Horie,
K.Sugata,
Y.Hoshikawa,
T.Sata,
and
T.Sairenji
(2007).
The vIL-10 gene of the Epstein-Barr virus (EBV) is conserved in a stable manner except for a few point mutations in various EBV isolates.
|
| |
Virus Genes,
35,
563-569.
|
 |
|
|
|
|
 |
S.I.Yoon,
and
M.R.Walter
(2007).
Identification and characterization of a +1 frameshift observed during the expression of Epstein-Barr virus IL-10 in Escherichia coli.
|
| |
Protein Expr Purif,
53,
132-137.
|
 |
|
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2006).
Survey of the year 2005 commercial optical biosensor literature.
|
| |
J Mol Recognit,
19,
478-534.
|
 |
|
|
|
|
 |
S.I.Yoon,
N.J.Logsdon,
F.Sheikh,
R.P.Donnelly,
and
M.R.Walter
(2006).
Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex.
|
| |
J Biol Chem,
281,
35088-35096.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |